Levothyroxine (Synthroid, Eltroxin) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 10, 2026
Some Levothyroxine products are in shortage in Canada (1 of 31 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A thyroid hormone replacement used to treat an underactive thyroid (hypothyroidism).
Products affected
1 / 31
In shortage since
Apr 28, 2026
Reports on file
80
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-LEVOTHYROXINE
112MCG · TABLET · APOTEX INC
DIN 02550741 · since Apr 28, 2026, est. end May 8, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
200MCG · TABLET · APOTEX INC
DIN 02550806 · ended Jan 15, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
50MCG · TABLET · APOTEX INC
DIN 02550717 · ended Nov 13, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
112MCG · TABLET · APOTEX INC
DIN 02550741 · ended Nov 6, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
50MCG · TABLET · APOTEX INC
DIN 02550717 · ended Nov 6, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
137MCG · TABLET · APOTEX INC
DIN 02550776 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
125MCG · TABLET · APOTEX INC
DIN 02550768 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
88MCG · TABLET · APOTEX INC
DIN 02550733 · ended Oct 30, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
125MCG · TABLET · APOTEX INC
DIN 02550768 · ended Oct 23, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
75MCG · TABLET · APOTEX INC
DIN 02550725 · ended Oct 15, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
100MCG · TABLET · APOTEX INC
DIN 02534681 · ended Oct 15, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-LEVOTHYROXINE
75MCG · TABLET · APOTEX INC
DIN 02550725 · ended Oct 9, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Levothyroxine is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Levothyroxine is classified under “THYROID PREPARATIONS” (ATC H03AA).
Recent changes
Jul 10, 2026
Shortage resolved
Common questions
What is Levothyroxine used for?
A thyroid hormone replacement used to treat an underactive thyroid (hypothyroidism).
When will Levothyroxine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Levothyroxine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.